Samil Pharmaceutical "No Supply Issues for Cold Medicine 'Eorinibuprofen Syrup'... Full Effort to Secure Inventory"

Sam-il Pharmaceutical Children's Brufen Syrup.

[Asia Economy Reporter Lee Gwan-joo] As the supply of cold medicine faces an emergency amid the resurgence of COVID-19, Samil Pharmaceutical, which supplies the representative children's fever reducer 'Burofen,' announced on the 1st that it is working hard to secure inventory.

Samil Pharmaceutical stated on the same day, "We are making efforts to secure inventory of Children's Burofen Syrup in preparation for a situation similar to the children's fever reducer shortage crisis that occurred last March."

Children's Burofen Syrup has been a steady seller product for 35 years since its launch in 1987. It has antipyretic, analgesic, and anti-inflammatory effects, making it effective for fever, headache, and body aches caused by colds.

A Samil Pharmaceutical official explained, "We are striving to secure inventory exceeding the average monthly sales volume to prepare for the increase in confirmed cases," adding, "Even during the company-wide vacation period, some personnel on the Children's Burofen Syrup production line are working to make every effort to secure inventory."